+
+

Related Products

  • SciSure
    295 Ratings
    Visit Website
  • RegDesk
    16 Ratings
    Visit Website
  • QBench
    134 Ratings
    Visit Website
  • Lockbox LIMS
    68 Ratings
    Visit Website
  • SAP S/4HANA Cloud Public Edition
    3,466 Ratings
    Visit Website
  • Qualio
    823 Ratings
    Visit Website
  • Digital WarRoom
    55 Ratings
    Visit Website
  • FrameworkLTC
    47 Ratings
    Visit Website
  • JDisc Discovery
    27 Ratings
    Visit Website
  • AthenaHQ
    18 Ratings
    Visit Website

About

BenevolentAI is an AI-enabled drug discovery platform and scientific technology company that unites advanced artificial intelligence, machine learning, and domain-specific science to accelerate the discovery, design, and development of new medicines for complex diseases by making sense of vast, diverse biomedical data and generating actionable scientific insights faster than traditional methods. Its proprietary Benevolent Platform ingests and harmonizes structured and unstructured biomedical information, including literature, genomics, clinical information, and multi-omics data, into a comprehensive knowledge graph, enabling scientists to reason across biological systems, generate hypotheses, predict novel drug targets, and design candidate molecules with higher confidence and lower failure rates.

About

Bringing a new drug into the market, from the first step to the final market introduction, is a time-consuming, highly regulated, and expensive process, which can take a decade or more. Final success crucially depends on the early availability of accurate analytical results, fast enough for taking the right decisions at the beginning of the development and minimizing late attrition rates. Today’s drug development is mainly based on a rational approach where typically establishing the biological target to focus on is the first key step. This target identification requires a deep understanding of the candidates´ properties to identify the most promising ones as quickly and reliable as possible. Once a biological target has been established, finding the most promising lead molecules is often seen as the next challenge. Typically, lead discovery is the identification of potential drug candidates – either small organic molecules or biologic assemblies with therapeutic potential.

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Audience

Researchers, biopharma teams, and drug discovery professionals requiring a solution to uncover biological insights, identify therapeutic targets, and accelerate the development of new medicines

Audience

Drug Discovery solution for pharma and biopharma companies

Support

Phone Support
24/7 Live Support
Online

Support

Phone Support
24/7 Live Support
Online

API

Offers API

API

Offers API

Screenshots and Videos

Screenshots and Videos

Pricing

No information available.
Free Version
Free Trial

Pricing

No information available.
Free Version
Free Trial

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Training

Documentation
Webinars
Live Online
In Person

Training

Documentation
Webinars
Live Online
In Person

Company Information

BenevolentAI
Founded: 2013
Luxembourg
www.benevolent.com

Company Information

Bruker
Founded: 1960
United States
www.bruker.com/en/applications/pharma/drug-discovery.html

Alternatives

Alternatives

SILCS

SILCS

SilcsBio
Scitara DLX

Scitara DLX

Scitara
BIOVIA Discovery Studio

BIOVIA Discovery Studio

Dassault Systèmes

Categories

Categories

Integrations

No info available.

Integrations

No info available.
Claim BenevolentAI and update features and information
Claim BenevolentAI and update features and information
Claim Bruker Drug Discovery and update features and information
Claim Bruker Drug Discovery and update features and information